GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia
Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), Kirsten M. Williams(National Institutes of Health), Leo F. Verdonck(Isala), Melhem Solh(Johns Hopkins Hospital), James Gajewski(The University of Texas MD Anderson Cancer Center), Christopher Bredeson, Attaphol Pawarode(University of Michigan), Margaret L. MacMillan(University of Minnesota Medical Center), Niketa C. Shah, Gerhard Hildebrandt(University of Missouri Health System), Navneet S. Majhail(Sarah Cannon), Yoshihiro Inamoto, Saurabh Chhabra(Medical College of Wisconsin), Medhat Askar(Baylor University Medical Center), Jeff Szer(The Royal Melbourne Hospital), Ibrahim Ahmed(Children's Mercy Hospital), Amin M. Alousi(McGill University), Muna Qayed(Emory University), Shernan G. Holtan(University of Minnesota), Thomas R. Spitzer(Harvard University), Peiman Hematti(UW Health University Hospital), Takanori Teshima(Hokkaido University Hospital), Michael Hemmer(McGill University), Vijaya Raj Bhatt(Susan Thompson Buffett Foundation), Sachiko Seo(National Cancer Center Hospital East), Mukta Arora(Fairview Health Services), Kirk R. Schultz(University of British Columbia), Taiga Nishihori(Moffitt Cancer Center), Hemalatha G. Rangarajan(Nationwide Children's Hospital), Stephen R. Spellman(National Marrow Donor Program), Daniel R. Couriel(The University of Texas MD Anderson Cancer Center), Ami J. Shah(University of California, Los Angeles), Carrie L. Kitko(Vanderbilt University Medical Center), Usama Gergis(Thomas Jefferson University Hospital), Hisham Abdel‐Azim(University of Southern California), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Richard F. Olsson(AstraZeneca (Netherlands)), Pooja Khandelwal(Cincinnati Children's Hospital Medical Center), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Jeffery J. Auletta(Nationwide Children's Hospital), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Robert Peter Gale(Imperial College London), Bipin N. Savani(Vanderbilt University Medical Center), Tao Wang(Medical College of Wisconsin), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Parinda A. Mehta(Cincinnati Children's Hospital Medical Center), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Tim Prestidge(Starship Children's Health), Joseph Pidala(Moffitt Cancer Center), Olle Ringdén(Karolinska Institutet)
Cited by 20
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
|New England Journal of Medicine|2008|972